Kneipp Group has acquired Pierre Cattier
Kneipp France, a wholly owned subsidiary of the Kneipp Group in Würzburg, Germany, has acquired the French natural cosmetics manufacturer Pierre Cattier. Financial terms of this transaction have not been disclosed.
The Kneipp brand is synonymous with effective, innovative and natural product concepts for health and well-being based on the holistic teachings of Sebastian Kneipp. The Kneipp Group operates worldwide and is a wholly owned subsidiary of Paul Hartmann AG, Heidenheim. The company is looking to further strengthen its position in Germany and internationally by means of acquisitions.
Dietmar Salein, Managing Director of the Kneipp Group, and Daniel Aressy, the owner of Pierre Cattier, signed the purchase agreement for the acquisition of all shares of Pierre Cattier. Kneipp France and Pierre Cattier have merged into one company and will continue to operate under the name Pierre Cattier in France. The new company will be led by Cattier’s Managing Director Alexis Fort and will market both product lines.
Pierre Cattier has been producing and marketing certified natural cosmetics since 1968. Cattier products are organic cosmetics with no parabens, synthetic dyes or fragrances, and no paraffin oil.
Oaklins' team in Germany advised the Kneipp Group on the acquisition process by initiating the transaction and running a structured international search in Germany, Austria, Switzerland and France with the support of Oaklins' teams in Switzerland and France. After having identified a French transaction target, our German and France teams jointly concluded the process from originating the contact with the seller, reviewing the documentation, coordinating the due diligence and advising on the negotiations through to the successful closing of the transaction.
Talk to the deal team
Related deals
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn moreThyssen'sche Handelsgesellschaft has acquired h/p/cosmos sports & medical GmbH
Thyssen’sche Handelsgesellschaft mbH (THG), a German strategic holding company, has acquired a majority stake in h/p/cosmos sports & medical GmbH. Founder and former sole shareholder Franz Harrer, who built h/p/cosmos into a global leader in niche medical and sports diagnostics equipment, remains invested as a minority partner. THG will support the company’s international growth and innovation plans, while the existing management team continues to run the business.
Learn more